Ado-trastuzumab emtansine Intravenous and Von Willebrand Factor

• Generic Name: ado-trastuzumab emtansine
• Dosage Forms: n.a.
• Other Brand Names: Kadcyla

Ado-trastuzumab emtansine injection is used to treat HER2-positive metastatic breast cancer (cancer that has spread to other parts of the body) in patients who have already received other medicines that did not work well. HER2 protein is produced by some breast tumors. Ado-trastuzumab emtansine interferes with the growth of this protein which also prevents tumor growth. The tumor cells will then be destroyed by the body.

Ado-trastuzumab emtansine is to be given only by or under the immediate supervision of your doctor.

• Generic Name: antihemophilic factor / von willebrand factor
• Dosage Forms: powder for solution, for intravenous use
• Other Brand Names: Alphanate, Humate-P, Wilate, Wilstart, Dried Factor VIII Fraction Type 8Y, Haemate P, Optivate

Antihemophilic and von Willebrand factors are naturally occurring proteins in the blood that help the blood to clot.

A lack of antihemophilic factor VIII is the cause of hemophilia A. A lack of von Willebrand factor is the cause of von Willebrand disease. antihemophilic and von Willebrand factor complex works by temporarily raising levels of factor VIII or von Willebrand factor in the blood to aid in clotting.

Antihemophilic and von Willebrand factor complex is a combination medicine used to treat or prevent bleeding episodes in people with von Willebrand disease.

Antihemophilic and von Willebrand factor complex is also used to treat or prevent bleeding episodes in people with hemophilia A.

Antihemophilic and von Willebrand factor complex may also be used for purposes not listed in this medication guide.